Pompe Pregnancy Sub-Registry

ClinicalTrials.gov ID: NCT00567073

Public ClinicalTrials.gov record NCT00567073. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 5, 2026, 10:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Sub-registry to Observe the Effect of Alglucosidase Alfa or Avalglucosidase Alfa Treatment on Pregnancy and Infant Growth in Women With Pompe Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Sub-registry is a multicenter, international, longitudinal, observational, and voluntary program designed to track pregnancy outcomes for any pregnant woman enrolled in the Pompe Registry, regardless of whether she is receiving disease-specific therapy (such as ERT with alglucosidase alfa or avalglucosidase alfa) and irrespective of the commercial product with which she may be treated. No experimental intervention is given; thus a patient will undergo clinical assessments and receive standard of care treatment as determined by the patient's physician. The primary objective of this Sub-registry is to track pregnancy outcomes, including complications and infant growth, in all women with Pompe disease during pregnancy, regardless of whether they receive disease-specific therapy, such as ERT with alglucosidase alfa or avalglucosidase alfa.

Study identification

NCT ID: NCT00567073
Recruitment status: Recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: Genzyme, a Sanofi Company; Industry
Enrollment: 20 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range: Not listed
Sex: Female
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 17, 2007
Primary completion: Jan 30, 2034
Completion: Jan 30, 2034
Last update posted: Apr 15, 2026

2007 – 2034

United States locations

U.S. sites: 15
U.S. states: 13
U.S. cities: 13

Facility	City	State	ZIP	Site status
Barrow Neurol Group- Site Number : 840087	Phoenix	Arizona	85013	Recruiting
University of Florida Pediatrics Genetics- Site Number : 157138	Jacksonville	Florida	32207	Recruiting
Emory University School Of Medicine- Site Number : 840060	Atlanta	Georgia	30322	Recruiting
Indianapolis University School of Medicine- Site Number : 840027	Indianapolis	Indiana	46202	Recruiting
University of Iowa- Site Number : 150294	Iowa City	Iowa	52242-1009	Recruiting
Spectrum for Health- Site Number : 840019	Grand Rapids	Michigan	49503	Recruiting
Washington University- Site Number : 150612	St Louis	Missouri	63110	Recruiting
New York University School Of Medicine- Site Number : 840040	New York	New York	10016	Recruiting
Mt. Sinai School of Medicine- Site Number : 840005	New York	New York	10029	Recruiting
Columbia University Irving Medical Center- Site Number : 157199	New York	New York	10032	Recruiting
Duke University Medical Center Genetics Dept- Site Number : 840037	Durham	North Carolina	27710	Recruiting
LSD Data Registry Site LLC- Site Number : 840094	Dublin	Ohio	43017	Recruiting
Oregon Health and Science University- Site Number : 840095	Portland	Oregon	97239	Completed
Greenwood Genetic Center - Greenville- Site Number : 151184	Greenville	South Carolina	29605	Recruiting
O & O Alpan- Site Number : 840025	Fairfax	Virginia	22030	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00567073, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 15, 2026 · Synced Sep 5, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00567073 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →